Toward an Entirely Endovascular World for Thoracoabdominal Aortic Disease: Myth or Reality?

Endovascular repair (ER) is currently the first-line treatment for the overwhelming majority of aortic disease, and its applicability is expanding to the whole aorta in light of evolving technologies. Whereas with the introduction of new devices developed to overcome common anatomical limitations, techniques of infrarenal (EVAR) and descending thoracic endovascular aneurysm repair (TEVAR) have reached a plateau; the debate is still open on thoracoabdominal aortic aneurysm (TAAA).